Skip to search formSkip to main contentSkip to account menu

Galantamine

Known as: Galanthamine, Lycoremine, Galantamine [Chemical/Ingredient] 
A benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor that has been used to… 
National Institutes of Health

Related topics

Related topics

32 relations
24 HR galantamine hydrobromide 16 MG Extended Release Oral Capsule [Razadyne]24 HR galantamine hydrobromide 8 MG Extended Release Oral CapsuleAlzheimer's DiseaseGalantamine 8 MG Oral Tablet
Expand

Broader (5)

AlkaloidsAminesCholinesterase InhibitorsNootropic Agents
Expand

Narrower (9)

Galantamine HydrochlorideNivalineRazadyneapogalanthamine
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
A review on Alzheimer's disease pathophysiology and its management: an update.
Review
2008
Review
2008
Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis
Pharmacologic treatments for Alzheimer’s disease include the cholinesterase inhibitors donepezil, galantamine, and rivastigmine… 
Review
2005
Review
2005
Drug discovery from medicinal plants.
Highly Cited
2003
Highly Cited
2003
Galantamine Is an Allosterically Potentiating Ligand of Neuronal Nicotinic but Not of Muscarinic Acetylcholine Receptors
Galantamine (Reminyl), an approved treatment for Alzheimer's disease (AD), is a potent allosteric potentiating ligand (APL) of… 
Review
2003
Review
2003
Treatment of Alzheimer's disease; current status and new perspectives
Highly Cited
2002
Highly Cited
2002
Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial
Highly Cited
2000
Highly Cited
2000
Galantamine in AD
Background: Galantamine is a reversible, competitive cholinesterase inhibitor that also allosterically modulates nicotinic… 
Highly Cited
2000
Highly Cited
2000
A 5-month, randomized, placebo-controlled trial of galantamine in AD
Objective: To investigate the efficacy and tolerability of galantamine, using a slow dose escalation schedule of up to 8 weeks… 
Highly Cited
2000
Highly Cited
2000
Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial
Abstract Objective: To evaluate the efficacy and safety of galantamine in the treatment of Alzheimer's disease. Design… 
Review
2000
Review
2000
Galantamine: a review of its use in Alzheimer's disease.
UNLABELLED Currently, acetylcholinesterase (AChE) inhibitors are the most promising class of drugs for the treatment of Alzheimer… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License